Rocuronium Bromide Injection, Solution
Product Images NDC 42677-310

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 42677-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shandong New Time Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mlcarton (10mlcarton)

Packaging label for Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) solution for intravenous use. The label indicates it contains 10 x 10 mL multiple dose vials. Warning states it is a paralyzing agent and for intravenous use only. The labeler is Shandong New Time Pharmaceutical Co., Ltd.*

FDA Label Image

10mlcontainer (10mlcontainer)

Label of Rocuronium Bromide Injection 100 mg/10 mL (10 mg/mL) multiple dose vial by Shandong New Time Pharmaceutical Co., Ltd. The label includes warnings of its paralyzing effects and instructions for intravenous use only. Storage conditions and manufacturing details are also provided.*

FDA Label Image

5mlcarton (5mlcarton)

Flat packaging label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) solution for intravenous use. The label indicates multiple dose vials, 10 x 5 mL per package. It includes a warning for paralyzing agent, is marked Rx only, and lists Shandong New Time Pharmaceutical Co., Ltd. as the manufacturer. The label features the NDC 42677-309-10 and a barcode.*

FDA Label Image

5mlcontainer (5mlcontainer)

Label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) multiple dose vial by Shandong New Time Pharmaceutical Co., Ltd. The label includes warnings for its paralyzing effects and respiratory arrest risk. Storage instructions specify refrigeration at 2° to 8°C and avoiding freezing. The packaging is latex-free, and it is for intravenous use only.*

FDA Label Image

Figure-1 (Figure 1)

A box plot graph displaying time in minutes on the vertical axis and dose in mg/kg on the horizontal axis across three age groups: 18–64 years, ≥ 65 years, and 1–12 years. The graph shows distribution of values with individual data points and variability for each group and dose level.*

FDA Label Image

Figure-2 (Figure 2)

A box plot chart depicting duration in minutes on the y-axis across different age groups and dosages of Rocuronium Bromide measured in mg/kg on the x-axis, including groups from 18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years.*

FDA Label Image

Figure-3 (Figure 3)

A line graph depicting the relationship between dose number (1 to 5) on the x-axis and time in minutes (0 to 30) on the y-axis. Two lines represent different doses (.1 mg/kg and .15 mg/kg) with corresponding sample sizes of N=29 and N=13, respectively. The .15 mg/kg dose shows higher time values across dose numbers compared to the .1 mg/kg dose.*

FDA Label Image

Structure- (Structure)

Chemical structure diagram of Rocuronium Bromide, displaying its steroidal framework with bromide ion. The image shows the molecular arrangement including functional groups typical of Rocuronium Bromide as used in the injection solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.